Cue Biopharma CUE
NASDAQ CUE
$23.98 -0.63 (-2.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Other Non-Current Liabilities (2018 - 2021)

Cue Biopharma (CUE) posted Other Non-Current Liabilities of $89000.0 for Q2 2021, down 93.33% sequentially from $1.3 million in Q1 2021.

Cue Biopharma (CUE) Other Non-Current Liabilities (2018 - 2021) Analysis & Trends

Cue Biopharma has reported Other Non-Current Liabilities for 4 years, with the latest figure at $89000.0 in Q2 2021.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $89000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $89000.0 (changed N/A YoY) and the FY2020 annual result came in at $1.9 million, down 51.78% from the prior year.
  • Other Non-Current Liabilities fell to $89000.0 in Q2 2021 per CUE's latest filing, from $1.3 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $6.4 million in Q2 2019 and troughed at $89000.0 in Q2 2021.
  • A 4-year average of $2.9 million and a median of $2.5 million in 2020 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2019 and 2020: Other Non-Current Liabilities jumped 774.37% in 2019, then plunged 76.78% in 2020.
  • Over 4 years, Other Non-Current Liabilities stood at $5.2 million in 2018, then fell by 22.36% to $4.0 million in 2019, then plunged by 51.78% to $1.9 million in 2020, then plunged by 95.41% to $89000.0 in 2021.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $89000.0, $1.3 million, and $1.9 million for Q2 2021, Q1 2021, and Q4 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Cue Biopharma 152.56 Mn 135.14 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 89,000.00
Mar 31, 2021 1.33 Mn
Dec 31, 2020 1.94 Mn
Sep 30, 2020 1.20 Mn
Mar 31, 2020 3.13 Mn
Dec 31, 2019 4.02 Mn
Sep 30, 2019 5.19 Mn
Jun 30, 2019 6.42 Mn
Mar 31, 2019 4.93 Mn
Dec 31, 2018 5.17 Mn
Sep 30, 2018 593,000.00
Jun 30, 2018 919,000.00